Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Green

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
The cancer and leukemia group B respiratory committeeEverett E Vokes, Michael C Perry, Hedy L Kindler, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)Gregory A Otterson, James E Herndon, Dorothy Watson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006Mark R Green, Afshin Dowlati, Lalitha Yellamraju, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancerEverett E Vokes, Jeffrey Crawford, Jeffrey Bogart, et al.
Cancer|January 30, 2002
Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group BCaio Max S Rocha Lima, James E Herndon, Michael Kosty, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient settingManan Shah, Katherine B Winfree, Patrick Peterson, et al.
American Journal of Clinical Oncology|February 6, 2004
Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332Elizabeth Johnson, Diana Lake, James E Herndon, et al.
Clinical Lung Cancer|December 5, 2003
Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA N2 non-small-cell lung cancerAnthony D Elias, Parvesh Kumar, James Herndon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104Ramaswamy Govindan, Xiaofei Wang, Maria Q Baggstrom, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901Stephen L Graziano, James E Herndon, Mark A Socinski, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
The cancer and leukemia group B respiratory committeeEverett E Vokes, Michael C Perry, Hedy L Kindler, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)Gregory A Otterson, James E Herndon, Dorothy Watson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006Mark R Green, Afshin Dowlati, Lalitha Yellamraju, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancerEverett E Vokes, Jeffrey Crawford, Jeffrey Bogart, et al.
Cancer|January 30, 2002
Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group BCaio Max S Rocha Lima, James E Herndon, Michael Kosty, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient settingManan Shah, Katherine B Winfree, Patrick Peterson, et al.
American Journal of Clinical Oncology|February 6, 2004
Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332Elizabeth Johnson, Diana Lake, James E Herndon, et al.
Clinical Lung Cancer|December 5, 2003
Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA N2 non-small-cell lung cancerAnthony D Elias, Parvesh Kumar, James Herndon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104Ramaswamy Govindan, Xiaofei Wang, Maria Q Baggstrom, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901Stephen L Graziano, James E Herndon, Mark A Socinski, et al.
Pageof 7